CJC-1295: a beginner's guide to the growth hormone peptide

Key takeaways

• CJC-1295 is a lab-made growth hormone-releasing hormone (GHRH) analog, a peptide that signals the pituitary to put out a longer, more sustained release of the body's own growth hormone. The studied long-acting version binds to albumin in your blood so it lasts for days . It has no approved medical use and is sold as a research chemical .
• It comes in two forms that are actually different molecules: a long-acting 'DAC' version, and a short-acting 'no-DAC' version that is really a peptide called Mod GRF 1-29. Nearly all the human data are on the DAC form, so the no-DAC products most people buy are the less-studied one .
• The human evidence is thin. The core data are two small 2006 studies in healthy adults, both on the long-acting form, showing it raises growth hormone and IGF-1 while keeping the natural pulse rhythm intact . No human trial backs the sleep, recovery, or body-composition claims people take it for.
• The FDA has not approved it and has flagged serious safety concerns for compounded peptides like this, including immune reactions (immunogenicity) and serious adverse events such as increased heart rate and a whole-body vasodilatory reaction .
• It is banned for tested athletes at all times, in and out of competition, as a growth hormone-releasing analogue named on the WADA prohibited list .

The short version: plausible mechanism, thin and form-mismatched proof

CJC-1295 is a synthetic peptide in a class called growth hormone-releasing hormone analogs, usually shortened to GHRH analogs. Instead of adding growth hormone from outside, it copies the natural signal that tells your pituitary gland to release a pulse of the hormone your body already makes . It is sold as a research chemical, not a medicine.

CJC-1295 is sold in two forms that are not the same drug, and mixing them up is the most common beginner mistake. The long-acting 'with DAC' version is built to grab onto albumin, a protein in your blood, so one dose keeps working for days . The short-acting 'no-DAC' version clears fast, which is why community protocols dose it more often. When an anti-doping lab analyzed a real 'CJC-1295' product, the no-DAC form turned out to be a separate peptide, Mod GRF 1-29 .

People take it as a small injection under the skin, usually from a freeze-dried vial they mix with liquid first. Whichever form you are looking at, the starting point is the same: an unapproved compound with a thin human evidence base and a lot of community confidence.

What people actually use it for

In peptide and gym circles, CJC-1295 is the partner peptide people pair with ipamorelin to try to amplify their own growth-hormone pulses. People reach for the combo hoping for deeper sleep, better recovery, and slow changes in body composition. The reported effects tend to be subtle and slow to build, not dramatic.

Almost all of that is anecdote. These are user reports and community habits, not results from controlled human trials. The two published human studies measured hormones in the blood, not sleep quality, muscle, or fat, so the reasons people actually take it have never been the target of a trial .

What the science actually shows

The human case is small, old, and mostly on the form people do not buy. In healthy adults, a single injection of the long-acting form raised growth hormone by 2 to 10 times for six days or more, and raised IGF-1, a growth marker in the blood, for nine to eleven days . A second study in healthy men found it did this while keeping the natural rhythm of growth-hormone pulses intact, which is the trait its reputation rests on .

Two things keep that from being a green light. The endpoints were hormone levels in the blood, not real-world results, so there is no trial evidence for muscle, fat loss, recovery, sleep, or long-term safety . And both studies used the long-acting DAC form, dosed by body weight in a lab, which is neither the short-acting no-DAC product most people buy nor the fixed-microgram amounts community protocols use .

The catch: unapproved, a cardiovascular signal, and banned in sport

• Not approved, and flagged by the FDA. There is no FDA-approved CJC-1295 product. The FDA lists it among bulk substances that may present significant safety risks for compounding, citing immunogenicity (the risk your immune system reacts to it) and limited clinical data .
• A real cardiovascular signal. The FDA says it has identified serious adverse events linked to CJC-1295, including increased heart rate and a systemic vasodilatory reaction, meaning blood vessels widening body-wide, which can bring flushing, warmth, and a drop in blood pressure . Stop and see a clinician for any adverse heart, hormone, or blood-sugar changes.
• It raises IGF-1, and nobody knows the long-term cost. The studies that make CJC-1295 look interesting work by pushing IGF-1 up . No trial has run long enough to say what sustained IGF-1 elevation does over years, so that risk is unmeasured, not ruled out.
• The two forms are easy to mix up. DAC and no-DAC are different molecules with very different dosing, and an unlabeled or mislabeled research vial makes the mistake easy . Get the form wrong and you get the dose and schedule wrong.
• What is in the vial is not checked. Because it is unapproved, nobody verifies what a research-chemical vial actually contains, so the amount and purity can vary and measuring mistakes are easy to make.
• Banned in sport. Growth hormone-releasing analogues are prohibited at all times under the WADA list, which USADA enforces, and CJC-1295 is named on it . Because it is not an approved medicine, a tested athlete has no approved therapeutic use to base an exemption on.
• Side effects people report: injection-site redness, a transient flush, and water retention are the common ones in user accounts. Stop and see a clinician for chest symptoms, a fast or pounding heartbeat, swelling, or blood-sugar changes.

How people take it, and where the real numbers live

If you are going to use it, the goal is to do it as safely as the unknowns allow, and step one is knowing which form is in your vial. Both forms ship as a freeze-dried powder you mix with bacteriostatic water before drawing a dose, and people inject under the skin. The no-DAC form is dosed more often because it clears fast; the DAC form is dosed every few days because it lasts.

None of the handling matters if the vial does not actually contain what the label says, and the research-chemical channel rarely comes with independent testing. What is really in the vial, and which form it is, is the assumption every other decision rests on, which is why the purity and form points above matter.

Where to read more

This guide is the on-ramp. When you want the full picture, CJC-1295 and ipamorelin vs pharmaceutical HGH weighs the peptide-stack approach against actual prescription growth hormone. The ipamorelin beginner guide covers the partner peptide most people pair it with. Sleep architecture and recovery explains how deep sleep and growth-hormone release connect, and injected peptides and natural production asks whether nudging your own hormones has a downside. Spotting high-quality peptides helps with the vial-quality problem. The CJC-1295 library entry is the quick reference for dosing ranges, storage, and sources.

How we sourced this, and the fine print

Every claim on this page is pinned to a published source: the two 2006 human studies of the long-acting form, the anti-doping lab analysis that identified the no-DAC peptide, the FDA compounding safety record, the recombinant growth-hormone label, and the WADA prohibited list. Where nobody has tested it in people yet, this guide says so rather than guessing.

For research and educational purposes only. Not medical advice.

pepSmart has not commissioned independent clinical review of this article.

More on how we write and source these guides: Editorial process and contributor disclosure and Sourcing posture.

Spot an error? Email corrections via /about.

Sources: 7 entries, all primary or authoritative government sources (PubMed, DailyMed, the FDA, USADA, and the WADA prohibited list), last reviewed 2026-07-13.

Related tools

• Protocol builder overview - Public overview of the Pro protocol builder.
• Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
• BAC water calculator - Solve BAC water volume for a target concentration.
• Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
• Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
• Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.